Cambridge tests SI-designed broad-spectrum bird flu vaccine in animals
Prepared by Sintelligent with the help of SI. Published in SI: . Updated: .
The method makes it possible to design a vaccine with future viral variants in mind, but protection in humans has yet to be confirmed.
Researchers collected genetic sequences of bird flu viruses from surveillance programmes worldwide and used computational and evolutionary algorithms to design five synthetic antigens covering the virus's diversity. In a Cell Reports Medicine study, the vaccine fully protected mice and ferrets against a range of genetically distinct variants that had previously infected humans; in the group given the existing WHO candidate vaccine, half of the animals survived. The next step is human clinical trials, and the team plans to apply the same method to seasonal influenza and other rapidly evolving RNA viruses.
Sources 1